Dr. Stephen Bentley Williams, MD

Dr. Williams practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Williams' NPI, 1952578536, was assigned on May 13, 2008. Dr. Williams graduated from George Washington University School of Medicine and Health Sciences in 2006. Dr. Williams holds Texas license P9767.

Dr. Williams' primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Williams' primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Williams to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Williams practices. Vendor and product names are available with a free account.

Urology is Dr. Williams' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Williams is board certified in urology by the American Board of Urology. Dmand AI has Dr. Williams' licenses on file in 3 states: Texas, California and Massachusetts.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney stone disease, prostate surgery, urinary endoscopy and urine flow blockage among the conditions Dr. Williams treats.

CMS data shows 275 Medicare services from Dr. Williams across 4 procedure codes in 2024, for 186 Medicare patients. Medicare paid $19,071 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 186 Medicare patients who saw Dr. Williams in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Williams' median patient age at 71, with 22% women.

In 2024, Dr. Williams wrote 238 Medicare Part D claims for 87 patients. 84% of them were for generic drugs. CMS names the drug for 151 of them, across 3 drugs with 11 or more claims each, at $21,480 in total drug cost. In 2023, CMS named 109 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Williams for performance year 2024, reported as part of a group. Dr. Williams accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 72 papers to Dr. Williams, published from 2004 to 2025. 2022 was the busiest year, with 13. The most frequent topics are Urinary Bladder Neoplasms, Cystectomy and Neoplasm Invasiveness. Dr. Williams has published most often in Urol Oncol. Dr. Williams' most frequent co-authors are Ashish M. Kamat, MD, Peter C. Black, MD and Stephen Browning Williams, MD.

CMS Open Payments shows 86 general payments to Dr. Williams from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 88% of the total. Janssen Research & Development, LLC paid the most, $37,704. It also lists 8 research payments totaling $19,530 from 2023 to 2025.

Dr. Williams graduated from George Washington University School of Medicine and Health Sciences in 2006.

Dr. Williams is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.